Martingale Asset Management’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-5,215
Closed -$275K 894
2022
Q2
$275K Sell
5,215
-18,203
-78% -$1.27M 0.01% 750
2022
Q1
$2.01M Sell
23,418
-3,761
-14% -$309K 0.03% 289
2021
Q4
$2.22M Sell
27,179
-5,600
-17% -$409K 0.03% 288
2021
Q3
$2.18M Sell
32,779
-363
-1% -$25.7K 0.03% 275
2021
Q2
$2.22M Sell
33,142
-3,106
-9% -$193K 0.03% 240
2021
Q1
$1.89M Sell
36,248
-2
-0% -$101 0.02% 281
2020
Q4
$1.45M Sell
36,250
-13,800
-28% -$445K 0.02% 356
2020
Q3
$1.23M Hold
50,050
0.01% 574
2020
Q2
$907K Hold
50,050
0.01% 756
2020
Q1
$721K Hold
50,050
0.01% 744
2019
Q4
$1.9M Sell
50,050
-2
-0% -$60 0.02% 604
2019
Q3
$1.11M Buy
50,052
+6,901
+16% +$147K 0.01% 745
2019
Q2
$892K Buy
+43,151
New +$995K 0.01% 800

Other funds holding THC

Martingale Asset Management's THC Position: Q3 2022 in Review

Martingale Asset Management sold out of Tenet Healthcare (THC) in Q3 2022, closing a stake of 5,215 shares — an estimated $275K sold.

Martingale Asset Management first reported a position in THC in Q2 2019 and held it in 13 quarters. The position peaked at $2.22M in Q4 2021. 360 funds tracked by Wall St. Rank hold THC as of Q3 2022.

  • Martingale Asset Management reported no remaining Tenet Healthcare position as of Q3 2022 after selling out during the quarter.
  • Martingale Asset Management sold 5,215 Tenet Healthcare shares in Q3 2022, an estimated $275K.
  • Martingale Asset Management first reported a position in Tenet Healthcare in Q2 2019 and held it in 13 quarters.
  • Martingale Asset Management's Tenet Healthcare position peaked at $2.22M in Q4 2021.
  • 360 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2022.

Based on Martingale Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.